171 related articles for article (PubMed ID: 36317216)
1. [Genetic diagnosis of a child with Café-au-lait macules and juvenile xanthogranuloma].
Lu X; Xiao F
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1266-1269. PubMed ID: 36317216
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of multiple café-au-lait macules for neurofibromatosis 1 in Chinese children.
Yao R; Wang L; Yu Y; Wang J; Shen Y
J Dermatol; 2016 May; 43(5):537-42. PubMed ID: 26458495
[TBL] [Abstract][Full Text] [Related]
3. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
Bernier A; Larbrisseau A; Perreault S
Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
[TBL] [Abstract][Full Text] [Related]
4. Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia.
Banerjee S; Lei D; Liang S; Yang L; Liu S; Wei Z; Tang JP
Oncotarget; 2017 Jun; 8(24):39695-39702. PubMed ID: 27980226
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of clinical features and variants of NF1 gene in 12 patients with Neurofibromatosis type 1].
Zhang Y; Yan L; Xie M; Xue J; Zhuang D; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Dec; 40(12):1478-1483. PubMed ID: 37994127
[TBL] [Abstract][Full Text] [Related]
6. JAAD Grand Rounds quiz. Café-au-lait macules and enlarging papules on the face.
Mallory M; Bryer BM; Wilson BB
J Am Acad Dermatol; 2013 Feb; 68(2):348-50. PubMed ID: 23317978
[No Abstract] [Full Text] [Related]
7. Characteristics of Café-au-lait Macules and their Association with the Neurofibromatosis type I Genotype in a Cohort of Greek Children.
Nasi L; Alexopoulos A; Kokkinou E; Roka K; Tzetis M; Tsipi M; Kakourou T; Kanaka-Gantenbein C; Chrousos G; Kattamis A; Pons R;
Acta Derm Venereol; 2023 Jun; 103():adv5758. PubMed ID: 37272364
[TBL] [Abstract][Full Text] [Related]
8. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
9. [Genetic analysis of a child with global developmental delay and neurofibromatosis type 1].
Zhang X; Shen G; Zhang J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Aug; 37(8):851-854. PubMed ID: 32761593
[TBL] [Abstract][Full Text] [Related]
10. Novel, heterozygous, de novo pathogenic variant (c.4963delA: p.Thr1656Glnfs*42) of the NF1 gene in a Chinese family with neurofibromatosis type 1.
Yang L; Fu J; Cheng J; Zhou B; Chen M; Anuchapreeda S; Fu J
BMC Med Genomics; 2023 Apr; 16(1):85. PubMed ID: 37095468
[TBL] [Abstract][Full Text] [Related]
11. [A case of growth hormone deficiency combined with neurofibromatosis Type 1 and its gene analysis].
Long X; Xiong J; Mo Z; Zhang Q; Jin P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jul; 43(7):811-815. PubMed ID: 30124220
[TBL] [Abstract][Full Text] [Related]
12. Legius Syndrome and its Relationship with Neurofibromatosis Type 1.
Denayer E; Legius E
Acta Derm Venereol; 2020 Mar; 100(7):adv00093. PubMed ID: 32147744
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis Type 1: Diagnostic Timelines in Children.
García-Martínez FJ; Hernández-Martín A
Actas Dermosifiliogr; 2023 Mar; 114(3):187-193. PubMed ID: 36370836
[TBL] [Abstract][Full Text] [Related]
14. A novel RAB39B mutation and concurrent de novo NF1 mutation in a boy with neurofibromatosis type 1, intellectual disability, and autism: a case report.
Santoro C; Giugliano T; Bernardo P; Palladino F; Torella A; Del Vecchio Blanco F; Onore ME; Carotenuto M; Nigro V; Piluso G
BMC Neurol; 2020 Sep; 20(1):327. PubMed ID: 32873259
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
[TBL] [Abstract][Full Text] [Related]
17. Choroidal abnormalities in café-au-lait syndromes: a new differential diagnostic tool?
Cassiman C; Casteels I; Jacob J; Plasschaert E; Brems H; Dubron K; Keer KV; Legius E
Clin Genet; 2017 Apr; 91(4):529-535. PubMed ID: 27716896
[TBL] [Abstract][Full Text] [Related]
18. Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.
Stewart DR; Brems H; Gomes AG; Ruppert SL; Callens T; Williams J; Claes K; Bober MB; Hachen R; Kaban LB; Li H; Lin A; McDonald M; Melancon S; Ortenberg J; Radtke HB; Samson I; Saul RA; Shen J; Siqveland E; Toler TL; van Maarle M; Wallace M; Williams M; Legius E; Messiaen L
Genet Med; 2014 Jun; 16(6):448-59. PubMed ID: 24232412
[TBL] [Abstract][Full Text] [Related]
19. Novel, heterozygous, pathogenic variant (c.4272delA: p.I1426Ffs*2) for the NF1 gene in a large Chinese family with neurofibromatosis type 1.
Yang L; Fu J; Cheng J; Zhou B; Liu X; Anuchapreeda S; Fu J
Mol Biol Rep; 2023 Feb; 50(2):1117-1123. PubMed ID: 36401065
[TBL] [Abstract][Full Text] [Related]
20. Mutation spectrum of the NF1 gene and genotype-phenotype correlations in Turkish patients: Seventeen novel pathogenic variants.
Ece Solmaz A; Isik E; Atik T; Ozkinay F; Onay H
Clin Neurol Neurosurg; 2021 Sep; 208():106884. PubMed ID: 34418705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]